Provider
Attention Deficit [Hyperactivity] Disorder (ADHD/ADD) Agents - Medicaid
Program effective Date: Jun 01, 2024
Documents & Forms Results
Displaying 1391 - 1400 of 3110 results
Provider
Pancreatic Enzymes - Commercial
Step Therapy
Program effective Date: Jun 01, 2024
Provider
QP44-24 MHCP Pharmacy Benefit Exclusion for Anktiva® and Docivyx™
Program effective Date: May 22, 2024
Provider
QP38-24 Training Webinars for New Prior Authorization Submission Process
Program effective Date: May 22, 2024
Provider
QP40-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2024
Program effective Date: May 08, 2024
Provider
QP37-24 Update for New-to-Market Medical Drugs: atidarsagene autotemcel, crovalimab, and fidanacogene eleparvovec
Program effective Date: May 08, 2024
Provider
QP43-24 MHCP Pharmacy Benefit Exclusion for Alyglo™ and Lenmeldy™
Program effective Date: May 08, 2024
Provider
QP42-24 Commercial Pharmacy Benefit Exclusion for Lenmeldy™
Program effective Date: May 08, 2024
Provider
QP41-24 Commercial Pharmacy Benefit Exclusion for Select Medications
Program effective Date: May 08, 2024
Provider
QP39-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2024
Program effective Date: May 08, 2024